Rectal Cancer Patients Clinical Trials

9 recruiting

Rectal Cancer Patients Trials at a Glance

9 actively recruiting trials for rectal cancer patients are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Ostrava, Guangzhou, and Guangzhou. Lead sponsors running rectal cancer patients studies include Sun Yat-sen University, Ruijin Hospital, and NanoEcho AB.

Browse rectal cancer patients trials by phase

Treatments under study

About Rectal Cancer Patients Clinical Trials

Looking for clinical trials for Rectal Cancer Patients? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Rectal Cancer Patients trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Rectal Cancer Patients clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 3

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

Rectal CancerRectal Cancer Patients
Shandong Cancer Hospital and Institute210 enrolled1 locationNCT06850090
Recruiting
Phase 2

Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.

Rectal Cancer Patients
Sun Yat-sen University88 enrolled1 locationNCT06911684
Recruiting
Phase 2

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01)

Rectal Cancer Patients
The Affiliated Hospital of Qingdao University35 enrolled1 locationNCT06647680
Recruiting
Not Applicable

Selective Total Mesorectal Excision Based on Intra-Operative Frozen Section From Local Excision in Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

Rectal Cancer Patients
Sun Yat-sen University27 enrolled1 locationNCT07337811
Recruiting
Phase 2

SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC

Rectal CancerRectal AdenocarcinomaTargeted Therapy+6 more
Ruijin Hospital104 enrolled1 locationNCT07198165
Recruiting
Not Applicable

Rectal Cancer CTC Trial

Rectal Cancer Patients
University Hospital Ostrava120 enrolled4 locationsNCT07194616
Recruiting
Not Applicable

Single-port Versus Multi-port Robotic Surgery for Rectal Cancer

Robotic Surgical ProceduresRectal Cancer Patients
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University40 enrolled1 locationNCT06824688
Recruiting

The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study

Rectal Cancer Patients
The Institute of Molecular and Translational Medicine, Czech Republic150 enrolled1 locationNCT07112937
Recruiting
Phase 2

To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.

Healthy VolunteersRectal Cancer Patients
NanoEcho AB12 enrolled1 locationNCT06693375